In either dataset, we found that primary breast cancers that expressed high-levels of ROR1 were more likely to lack expression of estrogen or progesterone receptors or HER2/Neu, consistent with the observation in breast cancer cell lines. This evidence concerns the gene ERBB2 and breast carcinoma.